CAPVAXIVE injektionsvæske, opløsning i fyldt injektionssprøjte
Active ingredient: nicht angegeben
View notice details →News topic
Expected end: Ende November 2026
All current shortage notices related to Expected end: Ende November 2026, structured by product, country, active ingredient and reporting period.
7 noticesEpistatus 10 mg mundhulevæske, opløsning
Active ingredient: nicht angegeben
View notice details →Zyprexa 10 mg pulver til injektionsvæske, opløsning (Cheplapharm)
Active ingredient: nicht angegeben
View notice details →Neurontin 800 mg filmovertrukne tabletter
Active ingredient: nicht angegeben
View notice details →Zeldox 80 mg kapsler, hårde
Active ingredient: Ziprasidon
View notice details →Bendroza 2,5+573 mg filmovertrukne tabletter
Active ingredient: Bendroflumethiazid, kaliumchlorid
View notice details →Salamol 100 mikrogram/dosis inhalationsspray, suspension
Active ingredient: Salbutamol (salbutamolsulfat)
View notice details →Plan supply. Connect sourcing and warehousing.
For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Improve sourcing and supply availability
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Pharma warehouse and pharmaceutical warehousing in Cheb
Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →